Centiva Capital, LP Novavax Inc Transaction History
Centiva Capital, LP
- $4.65 Billion
- Q4 2024
A detailed history of Centiva Capital, LP transactions in Novavax Inc stock. As of the latest transaction made, Centiva Capital, LP holds 11,959 shares of NVAX stock, worth $97,944. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,959Holding current value
$97,944% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding NVAX
# of Institutions
289Shares Held
92.9MCall Options Held
6.44MPut Options Held
9.4M-
Vanguard Group Inc Valley Forge, PA15.7MShares$129 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$97 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$91.3 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$63.1 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$47.4 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $641M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...